
Zachary Hill
Head of Portfolio Management at Horizon Investments. Provides insights on market action, tariff action, and the Federal Reserve.
Top 3 podcasts with Zachary Hill
Ranked by the Snipd community

12 snips
Nov 19, 2024 • 21min
The Risk of Trump Tariff Policy on Global Equities
Rob Haworth, Senior Investment Strategist at U.S. Bank, and Zachary Hill, Head of Portfolio Management at Horizon Investments, tackle the potential fallout from Trump's tariff policy on global equities. They discuss consumer health and corporate earnings amid economic uncertainty, showcasing resilience against inflation. The duo also highlights investment opportunities beyond U.S. borders, particularly in Europe and Asia, as well as insights on the upcoming BOJ rate hike and its implications. Expect strategies for navigating the evolving market landscape!

6 snips
Feb 6, 2025 • 19min
US-China Trade War Casts Shadow on Global Markets
Stephanie Leung, Chief Investment Officer at StashAway, shares her expertise on how recent US tariffs on China are shaking up global markets. Zachary Hill, Head of Portfolio Management at Horizon Investments, sheds light on market behavior during this turbulent time. They discuss the economic repercussions of the US-China trade war, including shifts in Asia-Pacific markets and the influence of tariffs on investment strategies. Additionally, advanced AI developments and their potential effects on the housing market in China are explored.

Jun 12, 2025 • 17min
Trump Says He'll Set Unilateral Tariffs; China's Biotech Boom
Zachary Hill, Head of Portfolio Management at Horizon Investments, shares keen insights on the potential impacts of President Trump's unilateral tariffs, revealing how they could escalate trade tensions despite recent positive talks. He also discusses market dynamics influenced by U.S. debt levels and the Federal Reserve's strategies. On the biotech front, the podcast explores China's booming industry, spotlighting partnerships with major pharmaceutical firms and the country's growing role as a global competitor in biotech innovation.